Hideyuki Arita

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

Hideyuki Arita, Yoshitaka Narita, Shintaro Fukushima et al. · Acta Neuropathologica · 2013 · 369 citations

Neuro-oncology, Adult Malignant Gliomas, Total 1P19q +11

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 257 citations · Full text

Recurrent mutations of <scp><i>CD79B</i></scp> and <scp><i>MYD88</i></scp> are the hallmark of primary central nervous system lymphomas

Taishi Nakamura, Kensuke Tateishi, T. Niwa et al. · Neuropathology and Applied Neurobiology · 2015 · 220 citations

Revisiting <scp><i>TP</i></scp><i>53</i> Mutations and Immunohistochemistry—A Comparative Study in 157 Diffuse Gliomas

Hirokazu Takami, Akihiko Yoshida, Shintaro Fukushima et al. · Brain Pathology · 2014 · 144 citations · Full text

Pathology, High-grade Gliomas, Glioma +20

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi et al. · Acta Neuropathologica · 2021 · 103 citations

Neuro-oncology, Somatic Variant, Medicine +9